188 related articles for article (PubMed ID: 2235089)
1. [Cancer of the breast. Genetic alterations and prognostic factors].
Bièche I; Champème MH; Lidereau R
Pathol Biol (Paris); 1990 Sep; 38(7):727-34. PubMed ID: 2235089
[TBL] [Abstract][Full Text] [Related]
2. [Molecular analysis of breast cancers: recent developments].
Bièche I; Lidereau R
Bull Cancer; 1992; 79(12):1115-33. PubMed ID: 1304832
[TBL] [Abstract][Full Text] [Related]
3. [Cytogenetic abnormalities, genetic alterations, and applications for genetic diagnosis in breast cancer].
Tsukamoto K; Emi M; Nakamura Y
Nihon Rinsho; 1996 Dec; 54(12):3389-97. PubMed ID: 8976125
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
5. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
[TBL] [Abstract][Full Text] [Related]
6. [A new marker of aggressivity of breast cancers: loss of heterozygote on chromosome 7q].
Bièche I; Champème MH; Matifas F; Hacène K; Lidereau R
Bull Cancer; 1992; 79(9):865-72. PubMed ID: 1486222
[TBL] [Abstract][Full Text] [Related]
7. Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy.
Lizard-Nacol S; Lidereau R; Collin F; Arnal M; Hahnel L; Roignot P; Cuisenier J; Guerrin J
Cancer Res; 1995 Oct; 55(19):4416-9. PubMed ID: 7671254
[TBL] [Abstract][Full Text] [Related]
8. [Biology of solid cancers: breast cancer as an example. Second part: gene disregulation in breast cancer].
Bièche I; Lidereau R
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):142-52. PubMed ID: 8690862
[TBL] [Abstract][Full Text] [Related]
9. Quantitative detection of amplification of proto-oncogenes in breast cancer.
Chen Y; Dong J; Lu Y; McGee JO
Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
[TBL] [Abstract][Full Text] [Related]
10. Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease.
Zhou DJ; Ahuja H; Cline MJ
Oncogene; 1989 Jan; 4(1):105-8. PubMed ID: 2915899
[TBL] [Abstract][Full Text] [Related]
11. Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression.
Tsuda H
Breast Cancer; 2009; 16(3):186-201. PubMed ID: 19472036
[TBL] [Abstract][Full Text] [Related]
12. [Amplification of c-myc and c-erbbeta-2(HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters].
Lizard-Nacol S; Arnould L; Riedinger JM; Arnal M; Collin F; Guerrin J
Bull Cancer; 1994 Sep; 81(9):780-4. PubMed ID: 7703567
[TBL] [Abstract][Full Text] [Related]
13. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.
Tsuda H; Hirohashi S; Shimosato Y; Hirota T; Tsugane S; Yamamoto H; Miyajima N; Toyoshima K; Yamamoto T; Yokota J
Cancer Res; 1989 Jun; 49(11):3104-8. PubMed ID: 2566377
[TBL] [Abstract][Full Text] [Related]
14. The genetics of sporadic breast cancer.
Brenner AJ; Aldaz CM
Prog Clin Biol Res; 1997; 396():63-82. PubMed ID: 9108590
[TBL] [Abstract][Full Text] [Related]
15. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
[TBL] [Abstract][Full Text] [Related]
16. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer.
Zhou D; Battifora H; Yokota J; Yamamoto T; Cline MJ
Cancer Res; 1987 Nov; 47(22):6123-5. PubMed ID: 3664511
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
18. Proto-oncogene amplification and human breast tumor phenotype.
Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
[TBL] [Abstract][Full Text] [Related]
19. Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma.
Ali IU; Campbell G; Lidereau R; Callahan R
Oncogene Res; 1988 Sep; 3(2):139-46. PubMed ID: 3226722
[TBL] [Abstract][Full Text] [Related]
20. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
